Zhejiang Tailin Life Science Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 40 million on April 18, 2022. The transaction will include participation from returning investor Zhejiang Tailin BioEngineering Co.,Ltd. The transaction has been approved at the fifth meeting of the third board of directors of Zhejiang Tailin BioEngineering Co.,Ltd. Post the closing, the registered capital of the company will increase from CNY 10 million to CNY 50 million.
Zhejiang Tailin BioEngineering Co.,Ltd
Equities
300813
CNE100003S89
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.47 CNY | +0.49% | -3.40% | -16.52% |
1st Jan change | Capi. | |
---|---|---|
-16.52% | 307M | |
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |
- Stock Market
- Equities
- 300813 Stock
- News Zhejiang Tailin BioEngineering Co.,Ltd
- Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd